Efficacy of Udumbara Moola Jala as Pathya Kalpa in Management of Mutrakrichhra: A Single-Arm Clinical Trial
DOI:
https://doi.org/10.47552/ijam.v17i1.6608Keywords:
Ayurveda, Pathya Kalpa, Udumbara, Mutrakrichhra, Udumbar Jala, Urinary tract infectionAbstract
Abstract
Background: Mutrakrichhra (urinary tract infection) is characterized by painful micturition, burning sensation, and urinary frequency. Current antibiotic therapy faces challenges of antimicrobial resistance and side effects, necessitating the exploration of complementary interventions. Udumbara Moola Jala (Ficus racemosa root sap) represents a traditional Ayurvedic Pathya Kalpa with Sheeta Virya (cooling potency) and Pitta-shamaka properties.
Objective: To evaluate the clinical efficacy of Udumbara Moola Jala as a Pathya Kalpa in managing Mutrakrichhra symptoms.
Methods: A single-arm, pre-post interventional clinical trial was conducted at Bharati Vidyapeeth (Deemed to be University) Ayurved Hospital, Pune, from April 2024 to July 2025. Thirty participants aged 18-50 years with Mutrakrichhra symptoms received 20 mL of authenticated Udumbara Moola Jala twice daily before meals for seven days. Primary outcomes included Visual Analogue Scale assessment for pain, graded scales for burning micturition, and urinary frequency. Secondary outcomes comprised urine pus cell count and total WBC count. Ethical approval was obtained, and the study was registered with the Clinical Trial Registry of India.
Results: Significant improvements were observed across all parameters (p<0.001): lower abdominal pain decreased by 87.73% (5.43 to 0.67), pain during micturition by 85.63% (5.80 to 0.83), burning micturition by 81.63% (1.63 to 0.30), and urinary frequency by 75.51% (1.63 to 0.40). Objective parameters showed a 69.70% reduction in urine pus cells (2.20 to 0.67) and a 29.72% decrease in total WBC count (10,263.33 to 7,213.33).
Conclusions: Udumbara Moola Jala demonstrates significant therapeutic efficacy as a safe, economical Pathya Kalpa intervention for Mutrakrichhra management, supporting integration as a complementary therapy in urinary tract infections.
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 International Journal of Ayurvedic Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The author hereby transfers, assigns, or conveys all copyright ownership to the International Journal of Ayurvedic Medicine (IJAM). By this transfer, the article becomes the property of the IJAM and may not be published elsewhere without written permission from the IJAM.
This transfer of copyright also implies transfer of rights for printed, electronic, microfilm, and facsimile publication. No royalty or other monetary compensation will be received for transferring the copyright of the article to the IJAM.
The IJAM, in turn, grants each author the right to republish the article in any book for which he or she is the author or editor, without paying royalties to the IJAM, subject to the express conditions that (a) the author notify IJAM in advance in writing of this republication and (b) a credit line attributes the original publication to IJAM.
